- Enovis to Participate in the 23rd Annual Needham Virtual Healthcare Conference
- Enovis Announces Fourth Quarter and Full Year 2023 Results
- Enovis™ to Highlight Latest Technologies Across the Orthopedic Care Continuum at 2024 AAOS Annual Meeting
- Enovis to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024
- Enovis Showcases New Foot & Ankle Offerings at the ACFAS Annual Meeting
- Enovis to Host Fourth Quarter and Full Year 2023 Conference Call on February 22nd
- Enovis Introduces the DonJoy ROAM™ OA Knee Brace
- Enovis finalise l’acquisition de LimaCorporate S.p.A.
- Enovis Conclui Aquisição da LimaCorporate S.p.A
- Enovis משלימה את רכישת LimaCorporate S.p.A
More ▼
Key statistics
On Thursday, Enovis Corp (ENOV:NYQ) closed at 62.45, -5.58% below its 52-week high of 66.14, set on Jul 21, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 62.05 |
---|---|
High | 62.63 |
Low | 61.95 |
Bid | 61.82 |
Offer | 63.11 |
Previous close | 62.46 |
Average volume | 359.59k |
---|---|
Shares outstanding | 54.62m |
Free float | 49.60m |
P/E (TTM) | -- |
Market cap | 3.41bn USD |
EPS (TTM) | -0.9987 USD |
Data delayed at least 15 minutes, as of Mar 28 2024 20:10 BST.
More ▼